...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Take Home Points: not ready for use in patients

Sorry...I misspoke.  I meant MACE rate improvements.  

I don't know if 124/164 (total of 288) eGFR sample group is sufficient for the FDA but it sure is a heck of a result.  I don't know of any drug that can do that...safely.

Share
New Message
Please login to post a reply